Microangiopathic antiphospholipid-associated syndromes revisited - New concepts relating to antiphospholipid antibodies and syndromes

Journal of Rheumatology

Volumn 34, Issue 9, 2007, Pages 1793-1795

  Asherson, Ronald A ^a   Pierangeli, Sylvia ^b   Cervera, Ricard ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ASHERSON SYNDROME; BLOOD VESSEL OCCLUSION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; EDITORIAL; HELLP SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROANGIOPATHIC ANTIPHOSPHOLIPID ASSOCIATED SYNDROME; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CAPILLARIES; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HELLP SYNDROME; HUMANS; PREGNANCY; PURPURA, THROMBOTIC THROMBOCYTOPENIC; VASCULAR DISEASES;

EID: 35948989213     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (39)

1. Asherson RA, Pierangeli S, Cervera R. Is there a microangiopathic antiphospholipid syndrome? Ann Rheum Dis 2007;66:429-32.
2. Asherson RA, Menahem S, Yinh J, Bucciarelli S, Espinosa G, Cervera R. Relapsing catastrophic antiphospholipid syndrome 2007. Semin Arthritis Rheum 2007; (submitted).
3. Espinosa G, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome and sepsis. A common link? J Rheumatol 2007;34:923-6.
4. Harris EN, Baguley E, Asherson RA, Hughes GRV. Clinical and serological features of the antiphospholipid syndrome (APS) [abstract]. Br J Rheumatol 1987;26 Suppl 2:19.
5. Asherson RA, Cervera R. The antiphospholipid syndrome: a syndrome in evolution. Ann Rheum Dis 1992;5:147-50.
6. Asherson RA, Cervera R, The antiphospholipid syndrome: multiple faces beyond the classical presentation. Autoimmun Rev 2003;3:140-51.
7. Asherson RA, Cervera R, Shepshelovich D, Shoenfeld Y. Nonthrombotic manifestations of the antiphospholipid syndrome: Away from thrombosis? [editorial]. J Rheumatol 2006;33:1038-44
8. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y. Immunization with a human monoclonal antibody (H-3). J Clin Invest 1992;89:1558-63.
9. Branch DW, Dudley DJ, Mitchell MD, et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990;163:210-6.
10. Pierangeli SS, Colden-Stanfield M, Liu X, Barker JH, Anderson GH, Harris EN. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 1999;99:1997-2000.
11. Jankowski M, Vreys I, Wittevrongel C, et al. Thrombogenicity of beta-2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood 2003;101:157-62.
12. Pierangeli SS, Girardi G, Vega-Ostertag ME, Liu X, Espinola RG, Salmon J. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 2005;52:2120-24.
13. Salmon JE, Girardi G, Holers VM. Activation of complement mediates antiphospholipid antibody-induced pregnancy loss. Lupus 2003;12:535-8.
14. Meroni PL, Raschi C, Testoni C, Borghi MO. Endothelial cell activation by antiphospholipid antibodies. Clin Immunol 2004;112:169-74.
15. Pierangeli SS, Liu X, Espinola R, et al. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb Haemost 2000;84:388-95.
16. Pierangeli SS, Espinola RG, Liu X, Harris EN. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P selectin. Circ Res 2001;88:245-50.
17. Espinola RG, Liu X, Colden-Stanfield M, Hall J, Harris EN, Pierangeli SS. E-selectin mediated pathogenic effects of antiphospholipid antibodies. J Thromb Haemost 2002;1:843-8.
18. Gharavi AE, Pierangeli SS, Colden-Stanfield M, Liu X, Espinola RG, Harris EN. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro. J Immunol 1999;163:2922-7.
19. Simantov E, LaSala J, Lo SK, et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995;96:2211-9.
20. Del Papa N, Guidali L, Sala A, et al. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta-2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta-2-glycoprotein I and induce endothelial cell activation. Arthritis Rheum 1997;40:551-61.
21. Zhou H, Woldberg AS, Roubey RA. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 2004;104:2353-8.
22. Vega-Ostertag M, Casper K, Swerlick R, Ferrara D, Harris EN, Pierangeli SS. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum 2005;52:1545-54.
23. Bohgaki M, Atsumi T, Yamashita Y, et al. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta-2-glycoprotein I antibodies. Int Immunol 2004;16:1632-41.
24. Lopez-Pedrera C, Buendia P, Cuadrado MJ, et al. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the activation of NF kappa-B/rel proteins via the P38 mitogen activated protein kinase pathway and of the MEK/ERK pathway. Arthritis Rheum 2006;54:201-11.
25. Vega-Ostertag ME, Harris EN, Pierangeli SS. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin. Arthritis Rheum 2004;50:2911-9.
26. Petri M. Epidemiology of the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette J-C, Shoenfeld Y, editors. The antiphospholipid syndrome. Amsterdam: Elsevier; 1996:13-27.
27. Miyakis S, Lockshin MH, Atsumi T, et al. International consensus statement on an update of the international classification for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
28. Merrill JT. Do antiphospholipid antibodies develop for a purpose? Curr Rheumatol Rep 2006;8:159-61.
29. Le Thi Thuong D, Tieulie N, Costedoat N, et al. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 2005;64:273-8.
30. Cervera R, Asherson RA. Primary pulmonary arterial hypertension and the systemic autoimmune diseases. Israel Med Assoc J 2006;8:277-9.
31. Rich S, Kieras K, Hart K, Groves BM, Stobo JD, Brundage BH. Primary pulmonary hypertension. J Am Coll Cardiol 1986;8:1307-11.
32. Holt PJ, Clague RB, Hay FC, Nineham IJ, Wade EG. Is idiopathic pulmonary hypertension a connective tissue disorder [abstract]. Arthritis Rheum 1980;23 Suppl:690.
33. Karmochkine M, Cacoub P, Dorent R, et al. High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension. J Rheumatol 1996;23:286-90.
34. Vanai-Landau H, Amital H, Bar-Dayan Y, et al. Autoimmune aspects of primary pulmonary hypertension. J Pathobiol 1995;63:71-5.
35. Pellicelli AM, D'Ambrosio C, Vizza CD, et al. HIV-related pulmonary hypertension. From pathogenesis to clinical aspects. Acta Cardiol 2004;59:323-30.
36. Korniszewski L, Kurzyna M, Stolarski B, Torbicki A, Smerdel A, Ploski R. Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome. Eur Respir J 2003;29;702-22.
37. Asherson RA, Higgenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GRV. Pulmonary hypertension in a lupus clinic: experience with twenty four patients. J Rheumatol 1990;17:1292-6.
38. Assous N, Allanore Y, Batteux F, et al. Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury. Clin Exp Rheumatol 2005;23:199-204.
39. Asherson RA, Bosman C, Tikly M, Spiro F, Pope FM. Ehlers-Danlos syndrome in a young man. J Rheumatol 2006;33:2091-6.